WallStreetZenWallStreetZen

NASDAQ: TCRT
Alaunos Therapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Alaunos Therapeutics earnings were -$4.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TCRT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$1.1M, up 44.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TCRT reported annual earnings of -$4.7M, with -86.7% growth.

TCRT earnings history

Current Revenue
$8.0k
Current Earnings
-$4.1M
Current Profit Margin
-50,887.5%

TCRT Return on Equity

Current Company
-169.3%
Current Industry
-60.2%
Current Market
31.5%
TCRT's Return on Equity (-169.3%)... subscribe to Premium to read more.
High Return on Equity Performance

TCRT undefined

Current Company
-124.3%
Current Industry
-2.5%
TCRT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TCRT announces earnings.

TCRT undefined

Current Company
-384.78%
Current Industry
5.8%
TCRT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TCRT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TCRT-$4.07M-$4.07MN/A-$2.54
MBIO-$10.54M-$10.71MN/A-$27.12
SNPX-$12.17M-$12.97MN/A-$10.00
ENSC-$6.77M-$6.82MN/A-$6.54
INDP-$15.75M-$15.75MN/A-$1.49
View Top Biotech Stocks

Alaunos Therapeutics Earnings Reports & History FAQ

What were Alaunos Therapeutics's earnings last quarter?

On TCRT's earnings call on Invalid Date, Alaunos Therapeutics (NASDAQ: TCRT) reported Q1 2025 earnings per share (EPS) of -$0.67, up 36.19% year over year. Total TCRT earnings for the quarter were -$1.07 million. In the same quarter last year, Alaunos Therapeutics's earnings per share (EPS) was -$1.05.

If you're new to stock investing, here's how to buy Alaunos Therapeutics stock.

Is Alaunos Therapeutics profitable or losing money?

As of the last Alaunos Therapeutics earnings report, Alaunos Therapeutics is currently losing money. Alaunos Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$4.07 million, a 84.79% decrease year over year.

What was TCRT's earnings growth in the past year?

As of Alaunos Therapeutics's earnings date in Invalid Date, Alaunos Therapeutics's earnings has grown year over year. TCRT earnings in the past year totalled -$4.07 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.